The National Cancer Institute (NCI) is offering this non-competitive grant to continue supporting the AIDS and Cancer Specimen Resource (ACSR). This grant is for ensuring the ongoing operation of an international repository vital for HIV and HIV-associated malignancy research. The ACSR provides a diverse collection of specimens from various global regions, genetic backgrounds, and disease eras, sourced from people with HIV, at-risk individuals, and controls from clinical trials and observational studies. It prospectively curates valuable specimens in the USA, sub-Saharan Africa, and Latin America, making them available to the research community at no cost. Additionally, the ACSR serves as the primary Biorepository for the NCI-funded AIDS Malignancy Consortium (AMC), supporting its domestic and international biorepositories.
Opportunity ID: 350843
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-CA-23-043 |
| Funding Opportunity Title: | Single Source: AIDS and Cancer Specimen Resource (ACSR; UM1 Clinical Trials Not Allowed) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Cooperative Agreement |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Nov 02, 2023 |
| Last Updated Date: | Nov 02, 2023 |
| Original Closing Date for Applications: | Jan 09, 2024 |
| Current Closing Date for Applications: | Jan 09, 2024 |
| Archive Date: | Feb 14, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | – |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. See full Notice of Funding Opportunity for additional details on eligibility. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | Through this non-competitive single source cooperative agreement Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits an application from (—–institute name—–) with the intent of funding a single award to continue to support the AIDS and Cancer Specimen Resource (ACSR). This is a reissue of RFA-CA-18-012. The ACSRs mission is to address the specimen needs of clinician and basic researchers in HIV and HIV-associated malignancy research. The ACSR is an international repository with specimens that reflect different eras of the epidemic (notably pre-cART and post-cART), different regions of the world, and people of diverse genetic backgrounds with different environmental exposures. Specimens have been obtained from people with HIV (PWH), people at risk for acquiring HIV, and HIV-uninfected controls. Specimens have been obtained from participants in clinical trials, observational cohort studies, or other research studies conducted by HIV investigators and consortium. The ACSR uses informed approaches to prospectively curate specimens in the USA, sub-Saharan Africa and Latin America that will be most valuable for the research community. Specimens and associated data are made available to the research community-at-large at NO COST. A second key role of the ACSR, is to serve as the AMC Biorepository for the AIDS Malignancy Consortium (AMC). The AMC is an NCI funded, multicenter clinical trials cooperative group that performs clinical trials research in the treatment and prevention of HIV-associated malignancies. The ACSR is currently providing support for domestic (two), sub-Saharan African, and Latin American biorepositories for the AMC. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/rfa-files/RFA-CA-23-043.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
Folder 350843 Full Announcement-RFA-CA-23-043 -> RFA-CA-23-043-Full-Announcement.pdf
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00283693 | Dec 08, 2023 | Jan 09, 2024 | View |
Package 1
Mandatory forms
350843 RR_SF424_5_0-5.0.pdf
350843 PHS398_CoverPageSupplement_5_0-5.0.pdf
350843 RR_OtherProjectInfo_1_4-1.4.pdf
350843 PerformanceSite_4_0-4.0.pdf
350843 RR_KeyPersonExpanded_4_0-4.0.pdf
350843 RR_Budget_3_0-3.0.pdf
350843 PHS398_ResearchPlan_5_0-5.0.pdf
350843 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
350843 RR_SubawardBudget30_3_0-3.0.pdf
350843 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
